Sub-category: Tissue Engineering & Cell Therapy
Medical field: Cardiovascular
BioGenCell is a biotechnology company developing medical therapeutic products for a wide range of diseases from adult stem cells extracted from the patient's blood. The company's mission is to become the provider of choice by leveraging groundbreaking technologies to create the fastest, safest, easiest to use and most cost-effective therapies, enabling physicians to successfully treat patients the day after diagnosis. BioGenCell is about to start clinical trials for its lead product after conclusively proving the concept behind the technology and its superiority in terms of safety, efficacy and production time.
BioGenCell’s technology platform provides a comprehensive and highly scalable solution for most aspects of cellular therapy, supporting rapid manufacturing of therapeutic cellular products from both fresh and bio-banked tissues. BGC101, the company's lead product, is produced from the patient’s own blood and requires only one treatment session with a long lasting therapeutic effect on blood vessel insufficiency which causes multiple vascular diseases and lead to organ failure in diabetic patients.
|Yael Porat, CEO|
|47 Herzel St., Hod-Hasharon|
To update your company data, click here.